Loading organizations...
§ Private Profile · Belfast, Belfast, United Kingdom
Biotechnology company using AI and synthetic biology for drug discovery, developing novel medicines for cancers and infectious diseases.
Based in Belfast, Northern Ireland, AMPLY Discovery is a 2021 spin-out from Queen's University Belfast that utilizes artificial intelligence, machine learning, and synthetic biology to discover novel biopharmaceuticals. Founded by Dr Ben Thomas, Dermot Tierney, and Professor Chris Creevey, the company's proprietary platform mines extensive biological datasets to identify therapeutic candidates for hard-to-treat diseases. These targets include aggressive oncology indications, such as triple-negative breast cancer and acute myeloid leukaemia, alongside metabolic conditions and drug-resistant infections. The enterprise develops proprietary drug candidates for clinical trials and pursues licensing partnerships with larger pharmaceutical corporations to advance its discoveries. AMPLY Discovery has secured over $3 million in total capital, highlighted by a $1.75 million seed round in 2025 and a €1.6 million grant in 2024, with backing from Twin Path Ventures, Techstars, QUBIS Ltd, and Innovate UK.
AMPLY Discovery has raised $3.5M across 2 funding rounds.
AMPLY Discovery has raised $3.5M in total across 2 funding rounds.
AMPLY Discovery has raised $3.5M in total across 2 funding rounds.
AMPLY Discovery's investors include Katie Lockwood, British Business Bank, QUBIS, Venture Science, Innosuisse, Innovate UK.
AMPLY Discovery has raised $3.5M across 2 funding rounds. Most recently, it raised $1.8M Seed in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2025 | $1.8M Seed | Katie Lockwood | British Business Bank, Qubis, Venture Science | Announced |
| Feb 12, 2024 | $1.8M Grant | Innosuisse, Innovate UK | — | Announced |